Citations

Clear

1432 citation(s) found for "Uk, Nathan".

Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high‐risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin‐amphotericin co
Abidi, Maheen Z. , Sohail, M. Rizwan , Wilhelm, Mark , Wengenack, Nancy L. , Brumble, Lisa , Shah, Harshal , Hata, D. Jane , McCullough, Ann E. , Wendel, Amy J., Vikram, Holenarasipur R. , Kusne, Shimon , Litzow, Mark R. , Letendre, Louis, Lahr, Brian D. , Poeschla, Eric M. , Walker, Randall C., Cummins, Nathan W. , Vikram, Holenarasipur R. , Sohail, M Rizwan , Abidi, Maheen Z , Abidi, Maheen Z

Mayo Clinic

Mycoses | July 18, 2014 | Volume: 57 | Issue: 11 | Pages: 687-698

10.1111/myc.12222 | PMID 25040241 Get It

SummaryAs invasive mucormycosis (IM) numbers rise, clinicians suspect prior voriconazole worsens IM incidence and severity, and believe combination anti‐fungal therapy improves IM survival. To compare the cumulative incidence (CI), severity and mortality of IM in eras immediately before and after the commercial availability of voriconazole all IM cases from 1995 to 2011 were analysed across four risk‐groups (hematologic/oncologic malignancy (H/O), stem cell transplantation (SCT), solid organ transplantation (SOT) and other), and two eras, E1 (1995–2003) and E2, (2004–2011). Of 101 IM cases, (79 proven, 22 probable): 30 were in E1 (3.3/year) and 71 in E2 (8.9/year). Between eras, the proportion with H/O or SCT rose from 47% to 73%, while ‘other’ dropped from 33% to 11% (P = 0.036). Between eras, the CI of IM did not significantly increase in SCT (P = 0.27) or SOT (P = 0.30), and patterns of anatomic location (P = 0.122) and surgical debridement (P = 0.200) were similar. Significantly more patients received amphotericin‐echinocandin combination therapy in E2 (31% vs. 5%, P = 0.01); however, 90‐day survival did not improve (54% vs. 59%, P = 0.67). Since 2003, the rise of IM reflects increasing numbers at risk, not prior use of voriconazole. Frequent combination of anti‐fungal therapy has not improved survival.
At the interface of sensory and motor dysfunctions and Alzheimer's disease
Gilmore, Grover C. , Kaye, Jeffrey , Murphy, Claire , Wingfield, Arthur , Bennett, David A. , Boxer, Adam L. , Buchman, Aron S. , Cruickshanks, Karen J., Devanand, Davangere P. , Duffy, Charles J., Gates, George A., Holtzer, Roee , Lin, Frank R. , McKee, Ann C. , Morris, John C. , Petersen, Ronald C. , Silbert, Lisa C. , Struble, Robert G., Trojanowski, John Q. , Verghese, Joe , Xu, Shunbin , Albers, Mark W. , Gall, Christine M. , Granholm, Ann‐Charlotte , Hensch, Takao K. , Hyman, Bradley T. , Wilson, Donald A. , Zhang, Li I. , Bennett, David A. , Morris, John C

Mayo Clinic

Alzheimer's & Dementia | July 8, 2014 | Volume: 11 | Issue: 1 | Pages: 70-98

10.1016/j.jalz.2014.04.514 | PMID 25022540 Get It

Abstract Recent evidence indicates that sensory and motor changes may precede the cognitive symptoms of Alzheimer's disease (AD) by several years and may signify increased risk of developing AD. Traditionally, sensory and motor dysfunctions in aging and AD have been studied separately. To ascertain the evidence supporting the relationship between age‐related changes in sensory and motor systems and the development of AD and to facilitate communication between several disciplines, the National Institute on Aging held an exploratory workshop titled “Sensory and Motor Dysfunctions in Aging and AD.” The scientific sessions of the workshop focused on age‐related and neuropathologic changes in the olfactory, visual, auditory, and motor systems, followed by extensive discussion and hypothesis generation related to the possible links among sensory, cognitive, and motor domains in aging and AD. Based on the data presented and discussed at this workshop, it is clear that sensory and motor regions of the central nervous system are affected by AD pathology and that interventions targeting amelioration of sensory‐motor deficits in AD may enhance patient function as AD progresses.
Abdominal Aortic Calcium, Coronary Artery Calcium, and Cardiovascular Morbidity and Mortality in the Multi-Ethnic Study of Atherosclerosis
Criqui, Michael H. , Denenberg, Julie O., McClelland, Robyn L. , Allison, Matthew , Guerci, Alan D., Cohoon, Kevin P. , Srikanthan, Preethi , Wong, Nathan D. , Allison, Matthew A, Guerci, Alan, Watson, Karol E., Ix, Joachim H. , Watson, Karol E. , Wong, Nathan , Allison, Matthew A

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | May 9, 2014 | Volume: 34 | Issue: 7 | Pages: 1574-1579

10.1161/atvbaha.114.303268 | PMID 24812323 Get It

Objective— To evaluate the predictive value of abdominal aortic calcium (AAC) for incident cardiovascular disease (CVD) independent of coronary artery calcium (CAC). Approach and Results— We evaluated the association of AAC with CVD in 1974 men and women aged 45 to 84 years randomly selected from the Multi-Ethnic Study of Atherosclerosis participants who had complete AAC and CAC data from computed tomographic scans. AAC and CAC were each divided into following 3 percentile categories: 0 to 50th, 51st to 75th, and 76th to 100th. During a mean of 5.5 years of follow-up, there were 50 hard coronary heart disease events, 83 hard CVD events, 30 fatal CVD events, and 105 total deaths. In multivariable-adjusted Cox models including both AAC and CAC, comparing the fourth quartile with the ≤50th percentile, AAC and CAC were each significantly and independently predictive of hard coronary heart disease and hard CVD, with hazard ratios ranging from 2.4 to 4.4. For CVD mortality, the hazard ratio was highly significant for the fourth quartile of AAC, 5.9 ( P =0.01), whereas the association for the fourth quartile of CAC (hazard ratio, 2.1) was not significant. For total mortality, the fourth quartile hazard ratio for AAC was 2.7 ( P =0.001), and for CAC, it was 1.9, P =0.04. Area under the receiver operating characteristic curve analyses showed improvement for both AAC and CAC separately, although improvement was greater with CAC for hard coronary heart disease and hard CVD, and greater with AAC for CVD mortality and total mortality. Sensitivity analyses defining AAC and CAC as continuous variables mirrored these results. Conclusions— AAC and CAC predicted hard coronary heart disease and hard CVD events independent of one another. Only AAC was independently related to CVD mortality, and AAC showed a stronger association than CAC with total mortality.
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
Jessen, Frank , Amariglio, Rebecca E. , Breteler, Monique M.B. , Ceccaldi, Mathieu , Chételat, Gaël , Dubois, Bruno , Dufouil, Carole , Ellis, Kathryn A. , Flier, Wiesje M. van der , Glodzik, Lidia , Harten, Argonde C. van , Leon, Mony J. de , McHugh, Pauline, Mielke, Michelle M. , Molinuevo, José Luís , Mosconi, Lisa , Osorio, Ricardo S. , Perrotin, Audrey , Petersen, Ronald C. , Rabin, Laura A., Rami, Lorena , Reisberg, ‌Barry , Sachdev, Perminder S. , Sayette, Vincent de La , Saykin, Andrew J. , Scheltens, Philip , Shulman, Melanie , Slavin, Melissa J., Stewart, Robert , Uspenskaya, Olga, Vellas, Bruno , Visser, Pieter Jelle , Wagner, Michael , Group, Subjective Cognitive Decline Initiative (SCD‐I) Working, Boxtel, Martin P.J. van , Rentz, Dorene M. , Sperling, Reisa Anne , Stewart, Robert , Group, Subjective Cognitive Decline Initiative (SCD‐I) Working, Mielke, Michelle M , Saykin, Andrew J , Sachdev, Perminder S , van der Flier, Wiesje M , Scheltens, Philip , Molinuevo, José Luis

Mayo Clinic

Alzheimer's & Dementia | May 3, 2014 | Volume: 10 | Issue: 6 | Pages: 844-852

10.1016/j.jalz.2014.01.001 | PMID 24798886 Get It

Abstract There is increasing evidence that subjective cognitive decline (SCD) in individuals with unimpaired performance on cognitive tests may represent the first symptomatic manifestation of Alzheimer's disease (AD). The research on SCD in early AD, however, is limited by the absence of common standards. The working group of the Subjective Cognitive Decline Initiative (SCD‐I) addressed this deficiency by reaching consensus on terminology and on a conceptual framework for research on SCD in AD. In this publication, research criteria for SCD in pre‐mild cognitive impairment (MCI) are presented. In addition, a list of core features proposed for reporting in SCD studies is provided, which will enable comparability of research across different settings. Finally, a set of features is presented, which in accordance with current knowledge, increases the likelihood of the presence of preclinical AD in individuals with SCD. This list is referred to as SCD plus .
Intensive care unit readmission prevention checklist: is it worth the effort?
O’Horo, John C. , Berrios, Ronaldo A. Sevilla, Whalen, Francis X. , Smischney, Nathan J. , Cawcutt, Kelly , Berrios, Ronaldo Sevilla , O'Horo, John C

Mayo Clinic

Journal of Evaluation in Clinical Practice | April 29, 2014 | Volume: 20 | Issue: 4 | Pages: 348-351

10.1111/jep.12135 | PMID 24779527 Get It

AbstractRationale, aims and objectivesChecklists have been adopted by various institutions to improve patient outcomes. In particular, readmission prevention checklists may be of potential value to improve patient care and reduce medical costs. As a result, a prior quality improvement study was conducted to create an intensive care unit readmission prevention checklist. The previous pilot demonstrated zero readmissions when the readmission prevention checklist was utilized but yielded low compliance (30%). Thus, a subsequent quality initiative was undertaken to refine the readmission prevention checklist with the primary aim of improved compliance while maintaining a reduced readmission rate that was observed with the original quality improvement study.MethodA single‐centre, cross‐sectional study for assessing baseline data and a prospective observational study to assess the effectiveness of a refined readmission prevention checklist tool in a 20‐bed tertiary medical‐surgical intensive care unit at an academic medical centre in Rochester, MN was conducted. Medical patients admitted through the emergency department, upon direct transfer from outside facility, and post‐operative surgical patients at our institution were included. A refined readmission prevention checklist tool was administered during an 8‐week pilot period for medical and post‐operative surgical patients.ResultsThe refined readmission prevention checklist resulted in an even lower compliance (10.5%) from the initial phase likely resulting from utilization of a paper readmission prevention checklist in an electronic medical environment. Moreover, the refined readmission prevention checklist demonstrated a 22% unplanned readmission rate for patients in which the tool was utilized.ConclusionsIn conclusion, the findings of the current quality improvement study may serve to rethink the process of health care delivery that applies paper tools in an electronic medical environment.
Mucormycosis in Patients with Inflammatory Bowel Disease: Case Series and Review of the Literature
Abidi, Maheen Z. , Weiland, Tim, Dyken, Irminne Van, Tande, Aaron J. , Tosh, Pritish K. , Walker, Randall C., Coelho-Prabhu, Nayantara , Tande, Aaron , Cummins, Nathan W. , Coelho–Prabhu, Nayantara , Hargreaves, James , Abidi, Maheen Z , Abidi, Maheen Z

Mayo Clinic

Case Reports in Medicine | April 27, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-7

10.1155/2014/637492 | PMID 24872818 Get It

Mucormycosis is a rare and often fatal invasive fungal infection mostly seen in immune-compromised individuals. A high index of clinical suspicion is necessary, so that effective preemptive therapy can be started, as timely intervention is crucial. In this series we present three cases of invasive mucormycosis in patients with underlying inflammatory bowel disease that had received therapy with immunomodulators prior to the infection. All three had varied clinical manifestations. We also review the literature of invasive mucormycosis in patients with inflammatory bowel disease.
Detection of 1α,25-Dihydroxyvitamin D-Regulated miRNAs in Zebrafish by Whole Transcriptome Sequencing
Craig, Theodore A., Zhang, Yuji , Magis, Andrew T. , Funk, Cory C. , Price, Nathan D. , Ekker, Stephen C. , Kumar, Rajiv , Price, Nathan D , Ekker, Stephen C , Kumar, Rajiv

Mayo Clinic

Zebrafish | March 20, 2014 | Volume: 11 | Issue: 3 | Pages: 207-218

10.1089/zeb.2013.0899 | PMID 24650217 Get It

Postsurgical Inflammatory Neuropathy Should Be Considered in the Differential Diagnosis of Diaphragm Paralysis after Surgery
Staff, Nathan P. , Dyck, P. James B. , Warner, Mark A. , Staff, Nathan P

Mayo Clinic

Anesthesiology | March 19, 2014 | Volume: 120 | Issue: 4 | Pages: 1057-1057

10.1097/aln.0000000000000130 | PMID 24694857 Get It